INSPIRE 6M Hollow Fiber Oxygenator; INSPIRE 6F M Hollow Fiber Oxygenator with Integrated Arterial Filter; INSPIRE 8M Hollow Fiber Oxygenator; INSPIRE 8F M Hollow Fiber Oxygenator with Integrated Arterial Filter by Sorin Group Italia S.r.l

INSPIRE 6F M is intended for use in adult surgical procedures requiring cardiopulmonary bypass. It provides gas exchange support and blood temperature control. INSPIRE 6F M integrated arterial filter provides additional protection against air and solid emboli. INSPIRE 6F M is intended to be used for 6 hours or less.

INSPIRE 6M is intended for use in adult and small adult surgical procedures requiring cardiopulmonary bypass. It provides gas exchange support and blood temperature control. INSPIRE 6M is intended to be used for 6 hours or less.

INSPIRE 8F M is intended for use in adult surgical procedures requiring cardiopulmonary bypass. It provides gas exchange support and blood temperature control. INSPIRE 8F M integrated arterial filter provides additional protection against air and solid emboli. INSPIRE 8F M is intended to be used for 6 hours or less.

The INSPIRE 8M is intended for use in adult and small adult surgical procedures requiring cardiopulmonary bypass. It provides gas exchange support and blood temperature control. INSPIRE 8M is intended to be used for 6 hours or less.

Device Description

The device consists of an oxygenator with an integrated heat exchanger. The INSPIRE model 6F M also has an integrated arterial filter. The INSPIRE 6F M device can be operated at flow rates up to 6 liters per minute (I/min). The hollow fiber membrane oxygenator provides oxygenation and carbon dioxide removal from venous blood or suction blood. The integrated heat exchanger controls blood temperature and allows the use of hypothermia or aids in the maintenance of normothermia during surgery. The integrated arterial filter provides additional protection against air and solid emboli. The device is a modified version of the currently marketed INSPIRE 6F M products.

The device consists of an oxygenator with an integrated heat exchanger. The INSPIRE 6M device can be operated at flow rates up to 6 liters per minute (I/min). The hollow fiber membrane oxygenator provides oxygenation and carbon dioxide removal from venous blood or suction blood. The integrated heat exchanger controls blood temperature and allows the use of hypothermia or aids in the maintenance of normothermia during surgery. The device is a modified version of the currently marketed INSPIRE 6M products.

The device consists of an oxygenator with an integrated heat exchanger. The INSPIRE model 8F M also has an integrated arterial filter. The INSPIRE 8F M device can be operated at flow rates up to 8 liters per minute (I/min). The hollow fiber membrane oxygenator provides oxygenation and carbon dioxide removal from venous blood or suction blood. The integrated heat exchanger controls blood temperature and allows the use of hypothermia or aids in the maintenance of normothermia during surgery. The integrated arterial filter provides additional protection against air and solid emboli. The device is a modified version of the currently marketed INSPIRE 8F M products.

The device consists of an oxygenator with an integrated heat exchanger. The INSPIRE 8M device can be operated at flow rates up to 8 liters per minute (I/min). The hollow fiber membrane oxygenator provides oxygenation and carbon dioxide removal from venous blood or suction blood. The integrated heat exchanger controls blood temperature and allows the use of hypothermia or aids in the maintenance of normothermia during surgery. The device is a modified version of the currently marketed INSPIRE 8M products.

AI/ML Overview

The provided document is a 510(k) premarket notification for several models of the INSPIRE Hollow Fiber Oxygenator. This type of submission is for demonstrating substantial equivalence to a predicate device, not necessarily for proving novel clinical effectiveness or "AI" performance.

Based on the information provided in the document:

1. A table of acceptance criteria and the reported device performance

Acceptance Criteria	Reported Device Performance
Moisture handling	Successfully met all acceptance criteria for moisture handling.

2. Sample size used for the test set and the data provenance

The document mentions "Testing was performed to compare devices with the modified and predicate gas outlet port." It states this was "in vitro test results" and conducted on "sterile aged devices; accelerated aging for a period of time equivalent to at least 3 years as per device labeling."

Sample size for the test set: Not explicitly stated. The document refers to "devices" in the plural, but the exact number is not provided.
Data provenance: In vitro testing, which means it's laboratory-based data, not human patient data. It is prospective testing designed to evaluate the modified device. The country of origin for the data is not specified, but the submitter is Sorin Group Italia S.r.l. in Mirandola (MO) ITALY.

3. Number of experts used to establish the ground truth for the test set and the qualifications of those experts

Not applicable. This was in vitro performance testing of a medical device, not a human reader study requiring expert opinion for ground truth.

4. Adjudication method for the test set

Not applicable. This was in vitro performance testing of a medical device against predefined engineering/performance criteria, not a study requiring adjudication of expert interpretations.

5. If a multi-reader multi-case (MRMC) comparative effectiveness study was done

No. This document describes in vitro testing of a device's physical and functional properties, not a reader study. There is no mention of human readers or AI assistance.

6. If a standalone (i.e., algorithm only without human-in-the-loop performance) was done

No. This is not an AI/algorithm-based device. It's a cardiopulmonary bypass oxygenator. The testing described is for the device itself.

7. The type of ground truth used

The "ground truth" for this in vitro performance testing would be the predefined engineering specifications and performance standards for moisture handling for oxygenator devices. The document states "successfully met all acceptance criteria for moisture handling," implying these criteria were established prior to the testing.

8. The sample size for the training set

Not applicable. This is not an AI/machine learning device that requires a training set.

9. How the ground truth for the training set was established

Not applicable. This is not an AI/machine learning device.

Summary

{0}------------------------------------------------

Image /page/0/Picture/0 description: The image contains the logo of the U.S. Food and Drug Administration (FDA). The logo consists of two parts: the Department of Health & Human Services logo on the left and the FDA logo on the right. The FDA logo includes the letters "FDA" in a blue square, followed by the words "U.S. FOOD & DRUG ADMINISTRATION" in blue text.

March 15, 2018

Sorin Group Italia S.r.l % Scott Light Senior Manager, Regulatory Affairs LivaNova USA, Inc. 14401 West 65th Way Arvada, Colorado 80004

Re: K180448

Trade/Device Name: INSPIRE 6M Hollow Fiber Oxygenator; INSPIRE 6F M Hollow Fiber Oxygenator with Integrated Arterial Filter; INSPIRE 8M Hollow Fiber Oxygenator; INSPIRE 8F M Hollow Fiber Oxygenator with Integrated Arterial Filter

Regulation Number: 21 CFR 870.4350 Regulation Name: Cardiopulmonary bypass oxygenator Regulatory Class: Class II Product Code: DTZ, DTR, DTM ("DTM" for the "F" models only) Dated: February 16, 2018 Received: February 13, 2018

Dear Scott Light:

We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal

{1}------------------------------------------------

statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (OS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.

Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.

For comprehensive regulatory information about mediation-emitting products, including information about labeling regulations, please see Device Advice (https://www.fda.gov/MedicalDevices/DeviceRegulationandGuidance/) and CDRH Learn (http://www.fda.gov/Training/CDRHLearn). Additionally, you may contact the Division of Industry and Consumer Education (DICE) to ask a question about a specific regulatory topic. See the DICE website (http://www.fda.gov/DICE) for more information or contact DICE by email (DICE@fda.hhs.gov) or phone (1-800-638-2041 or 301-796-7100).

Sincerely,

Nicole G. Ibrahim -S

for Bram D. Zuckerman, M.D. Director Division of Cardiovascular Devices Office of Device Evaluation Center for Devices and Radiological Health

Enclosure

{2}------------------------------------------------

510(k) Number (if known)

K180448

Device Name INSPIRE 6F M Hollow Fiber Oxygenator

Indications for Use (Describe)

Type of Use (Select one or both, as applicable)
	Prescription Use (Part 21 CFR 801 Subpart D)
	Over-The-Counter Use (21 CFR 801 Subpart C)

CONTINUE ON A SEPARATE PAGE IF NEEDED.

This section applies only to requirements of the Paperwork Reduction Act of 1995.

DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.

The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:

Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff(@fda.hhs.gov

{3}------------------------------------------------

510(k) Number (if known)

K180448

Device Name INSPIRE 6M Hollow Fiber Oxygenator

Indications for Use (Describe)

Type of Use (Select one or both, as applicable)

Prescription Use (Part 21 CFR 801 Subpart D)	Over-The-Counter Use (21 CFR 801 Subpart C)
---------------------------------------------------------------------------	--------------------------------------------------------------------------

CONTINUE ON A SEPARATE PAGE IF NEEDED.

This section applies only to requirements of the Paperwork Reduction Act of 1995.

DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.

Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff(@fda.hhs.gov

{4}------------------------------------------------

510(k) Number (if known)

K180448

Device Name INSPIRE 8F M Hollow Fiber Oxygenator

Indications for Use (Describe)

Type of Use (Select one or both, as applicable)

☒ Prescription Use (Part 21 CFR 801 Subpart D)
☐ Over-The-Counter Use (21 CFR 801 Subpart C)

CONTINUE ON A SEPARATE PAGE IF NEEDED.

This section applies only to requirements of the Paperwork Reduction Act of 1995.

DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.

Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff(@fda.hhs.gov

{5}------------------------------------------------

510(k) Number (if known)

K180448

Device Name INSPIRE 8M Hollow Fiber Oxygenator

Indications for Use (Describe)

Type of Use (Select one or both, as applicable)
☑ Prescription Use (Part 21 CFR 801 Subpart D)	☐ Over-The-Counter Use (21 CFR 801 Subpart C)

CONTINUE ON A SEPARATE PAGE IF NEEDED.

This section applies only to requirements of the Paperwork Reduction Act of 1995.

DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.

Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff(@fda.hhs.gov

{6}------------------------------------------------

SUBMITTER:	Sorin Group Italia S.r.I.86, Via Statale 12 Nord41037 Mirandola (MO) ITALY
CONTACT PERSON:	Luigi VecchiPhone: 39 0535 29811Fax: 39 0535 25229
DATE PREPARED:	March 6, 2018
DEVICE TRADE NAME:	INSPIRE 6F M
COMMON NAME:	Hollow fiber oxygenator
CLASSIFICATION NAME,REGULATION & PRODUCTCODE:	Cardiopulmonary Bypass Oxygenator, 870.4350, DTZCardiopulmonary Bypass Heat Exchanger, 870.4240, DTRCardiopulmonary Bypass Arterial Line Blood Filter, 870.4260, DTM
PREDICATE DEVICE:	INSPIRE 6F M (K120185)

DEVICE DESCRIPTION:

The device consists of an oxygenator with an integrated heat exchanger. The INSPIRE model 6F M also has an integrated arterial filter.

The INSPIRE 6F M device can be operated at flow rates up to 6 liters per minute (I/min).

The hollow fiber membrane oxygenator provides oxygenation and carbon dioxide removal from venous blood or suction blood. The integrated heat exchanger controls blood temperature and allows the use of hypothermia or aids in the maintenance of normothermia during surgery. The integrated arterial filter provides additional protection aqainst air and solid emboli.

The device is a modified version of the currently marketed INSPIRE 6F M products.

INDICATIONS FOR USE:

INSPIRE 6F M is intended for use in adult and small adult surgical procedures requiring cardiopulmonary bypass. It provides gas exchange support and blood temperature control. INSPIRE 6F M integrated arterial filter provides additional protection against air and solid emboli. INSPIRE 6F M is intended to be used for 6 hours or less.

TECHNOLOGICAL CHARACTERISTICS:

1. The size of the qas outlet port was changed from 1/4" to 3/8".
1. The Instructions for Use were revised to reflect the gas outlet port size change and provide additional information regarding moisture and the potential for obstructions.

{7}------------------------------------------------

1. The Instructions for Use were also updated to provide additional information and clarifications about the use of the device.

NON CLINICAL TEST RESULTS:

Additional ISO 10993-1 testing was not required as there were no changes to the device materials.

IN VITRO TEST RESULTS:

Testing was performed to compare devices with the modified and predicate gas outlet port. This performance testing was conducted on sterile aged devices; accelerated aging for a period of time equivalent to at least 3 years as per device labeling.

The oxygenating module with the modified gas outlet port successfully met all acceptance criteria for moisture handling.

CONCLUSIONS:

{8}------------------------------------------------

SUBMITTER:	Sorin Group Italia S.r.I.86, Via Statale 12 Nord41037 Mirandola (MO) ITALY
CONTACT PERSON:	Luigi VecchiPhone: 39 0535 29811Fax: 39 0535 25229
DATE PREPARED:	March 6, 2018
DEVICE TRADE NAME:	INSPIRE 6M
COMMON NAME:	Hollow fiber oxygenator
CLASSIFICATION NAME,REGULATION & PRODUCTCODE:	Cardiopulmonary Bypass Oxygenator, 870.4350, DTZCardiopulmonary Bypass Heat Exchanger, 870.4240, DTR
PREDICATE DEVICE:	INSPIRE 6M (K113626)

DEVICE DESCRIPTION:

The device consists of an oxygenator with an integrated heat exchanger.

The INSPIRE 6M device can be operated at flow rates up to 6 liters per minute (I/min).

The device is a modified version of the currently marketed INSPIRE 6M products.

INDICATIONS FOR USE:

TECHNOLOGICAL CHARACTERISTICS:

1. The size of the gas outlet port was changed from 1/4" to 3/8".
1. The Instructions for Use were revised to reflect the qas outlet port size change and provide additional information regarding moisture and the potential for obstructions.
1. The Instructions for Use were also updated to provide additional information and clarifications about the use of the device.

{9}------------------------------------------------

NON CLINICAL TEST RESULTS:

Additional ISO 10993-1 testing was not required as there were no changes to the device materials.

IN VITRO TEST RESULTS:

The oxygenating module with the modified gas outlet port successfully met all acceptance criteria for moisture handling.

CONCLUSIONS:

{10}------------------------------------------------

SUBMITTER:	Sorin Group Italia S.r.I.86, Via Statale 12 Nord41037 Mirandola (MO) ITALY
CONTACT PERSON:	Luigi VecchiPhone: 39 0535 29811Fax: 39 0535 25229
DATE PREPARED:	March 6, 2018
DEVICE TRADE NAME:	INSPIRE 8F M
COMMON NAME:	Hollow fiber oxygenator
CLASSIFICATION NAME,REGULATION &PRODUCT CODE:	Cardiopulmonary Bypass Oxygenator, 870.4350, DTZCardiopulmonary Bypass Heat Exchanger, 870.4240, DTRCardiopulmonary Bypass Arterial Line Blood Filter, 870.4260, DTM
PREDICATE DEVICE:	INSPIRE 8F M (K121536)

DEVICE DESCRIPTION:

The device consists of an oxygenator with an integrated heat exchanger. The INSPIRE model 8F M also has an integrated arterial filter.

The INSPIRE 8F M device can be operated at flow rates up to 8 liters per minute (I/min).

The device is a modified version of the currently marketed INSPIRE 8F M products.

INDICATIONS FOR USE:

INSPIRE 8F M is intended for use in adult and small adult surgical procedures requiring cardiopulmonary bypass. It provides gas exchange support and blood temperature control. INSPIRE 8F M integrated arterial filter provides additional protection against air and solid emboli. INSPIRE 8F M is intended to be used for 6 hours or less.

TECHNOLOGICAL CHARACTERISTICS:

1. The size of the gas outlet port was changed from 1/4" to 3/8".
1. The Instructions for Use were revised to reflect the gas outlet port size change and provide additional information regarding moisture and the potential for obstructions.

{11}------------------------------------------------

1. The Instructions for Use were also updated to provide additional information and clarifications about the use of the device.

NON CLINICAL TEST RESULTS:

Additional ISO 10993-1 testing was not required as there were no changes to the device materials.

IN VITRO TEST RESULTS:

The oxygenating module with the modified gas outlet port successfully met all acceptance criteria for moisture handling.

CONCLUSIONS:

{12}------------------------------------------------

SUBMITTER:	Sorin Group Italia S.r.I.86, Via Statale 12 Nord41037 Mirandola (MO) ITALY
CONTACT PERSON:	Luigi VecchiPhone: 39 0535 29811Fax: 39 0535 25229
DATE PREPARED:	March 6, 2018
DEVICE TRADE NAME:	INSPIRE 8M
COMMON NAME:	Hollow fiber oxygenator
CLASSIFICATION NAME,REGULATION & PRODUCTCODE:	Cardiopulmonary Bypass Oxygenator, 870.4350, DTZCardiopulmonary Bypass Heat Exchanger, 870.4240, DTR
PREDICATE DEVICE:	INSPIRE 8M (K121229)

DEVICE DESCRIPTION:

The device consists of an oxygenator with an integrated heat exchanger.

The INSPIRE 8M device can be operated at flow rates up to 8 liters per minute (I/min).

The device is a modified version of the currently marketed INSPIRE 8M products.

INDICATIONS FOR USE:

TECHNOLOGICAL CHARACTERISTICS:

1. The size of the gas outlet port was changed from 1/4" to 3/8".
1. The Instructions for Use were revised to reflect the qas outlet port size change and provide additional information regarding moisture and the potential for obstructions.
1. The Instructions for Use were also updated to provide additional information and clarifications about the use of the device.

{13}------------------------------------------------

NON CLINICAL TEST RESULTS:

Additional ISO 10993-1 testing was not required as there were no changes to the device materials.

IN VITRO TEST RESULTS:

The oxygenating module with the modified gas outlet port successfully met all acceptance criteria for moisture handling.

CONCLUSIONS:

Regulation Number and Section

§ 870.4350 Cardiopulmonary bypass oxygenator.

(a)
Identification. A cardiopulmonary bypass oxygenator is a device used to exchange gases between blood and a gaseous environment to satisfy the gas exchange needs of a patient during open-heart surgery.(b)
Classification. Class II (special controls). The special control for this device is the FDA guidance document entitled “Guidance for Cardiopulmonary Bypass Oxygenators 510(k) Submissions.”